News & Articles

Could ddPCR offer a rapid and reliable alternative to qPCR for replication-competent virus testing in gene therapy development?

Candida auris (C.auris) infections are a major global health challenge, with nosocomial outbreaks on the rise and many strains exhibiting resistance to antifungal agents. New real-time PCR tests enable sensitive and specific identification of the pathogen and of the most important mutations associated with resistance to echinocandins (ECH).

In the fast-paced world of science, knowledge drives progress, and The Bio-Rad Academy leads the charge

The new diagnostic system, which combines optofluidics and nanopores can test for COVID-19 and Zika virus

Discover the latest technology to supercharge your gene therapy vector analysis workflow

Agilent Technologies, Thermo Fisher Scientific, and Tecan among those recognized

Explore the latest technologies and techniques that will help you advance biopharma pipelines

A survey exploring the science behind cell and gene therapies highlights the tech at the heart of this breakthrough area

Cast your vote for the new product that has made the most difference to your research for the chance to win a $500 Amazon Gift Card (or equivalent currency)

Authors successfully demonstrate transport of new-gene editing technology to ‘cut out’ HIV DNA from infected cells

New mRNA-based therapies and vaccines could be developed more quickly and cheaply thanks to new manufacturing technologies developed at the University of Sheffield

Global Head of Medical Affairs at Agilent Technologies offers insights into the technologies driving the field of precision oncology

Navigating the complexities of food safety in a global supply chain

Explore the cutting-edge technologies and methods driving advancements in food quality, safety, and authenticity, from streamlined quality control monitoring to automated cryogen-free analysis systems

Explore how the latest advancements and recent regulatory approvals are making truly personalized medicine a reality

As we celebrate the first regulatory approval of a gene-editing based therapeutic, Casgevy™, for the treatment of sickle cell disease and transfusion-dependent β-thalassemia, we consider the gene-editing challenges that must be overcome before CRISPR gene-editing technology becomes a common treatment modality

With the QIAGEN nanoplate-based dPCR system, clinical scientists find better ways to diagnose invasive fungal disease and side-step antifungal therapy resistance

Watch this on-demand webinar to learn about monoclonal antibody-based human immune modulation in enhancing therapeutic outcomes

Tell us which new products have had the biggest impact on your lab work for a chance to win a $500 Amazon.com Gift Card (or equivalent currency)

Explore the latest developments in cancer research with fellow scientists, manufacturers, and regulatory experts

With the help of Bio-Rad’s ultra-sensitive, multiplexed digital PCR system, Biodesix and its research partners are pursuing novel blood tests for the early detection and targeted treatment of lung cancer

How small startups are being given the best opportunity for their ideas to flourish

EUROIMMUN offers a range of CE-marked ELISAs for determination of intrathecal antibodies in cerebrospinal fluid samples